Hepatitis B Virus
Patients with HBV more likely to receive guideline-adherent care if they also have HIV
Patients with hepatitis B virus were more likely to receive guideline-adherent care for their HBV infection if they also had HIV, a study found.
Heavy alcohol use increases liver impairment, risk for HCC in hepatitis-induced cirrhosis
Among patients with hepatitis-induced cirrhosis, heavy alcohol consumption increased liver function impairment and hepatocellular carcinoma prevalence, according to research.
TDF, postnatal immunization prevent vertical transmission of HBV
Researchers said the most effective approach to preventing vertical transmission of hepatitis B virus was a combination of maternal use of tenofovir disoproxil fumarate, or TDF, and postnatal immunization.
Immunoglobulin-free strategy prevents mother-to-child HBV transmission
Pregnant women with hepatitis B virus who received tenofovir disoproxil fumarate at least 4 weeks prior to delivery were less likely to transmit the virus to their infants, even those who did not receive immunoglobulin, data show.
Reminder alerts improve vaccination adherence among IBD patients
A quality improvement intervention increased vaccination adherence among patients with inflammatory bowel disease on immunosuppressive therapy, according to research presented at the Crohn’s and Colitis Congress.
HCV elimination: Importance of investment
Top in ID: US responds to Omicron variant, FDA approves novel HBV vaccine
Information related to the new omicron variant, including the United States’ response to it and details of its first case in the U.S, made up most of the top stories in infectious disease last week.
FDA approves trivalent hepatitis B vaccine for adults
VBI Vaccines announced that the FDA has approved the company’s recombinant trivalent hepatitis B vaccine, PreHevbrio, for adults aged 18 years or older.